US Patent Issued to Morphic Therapeutic on Sept. 16 for "Inhibitors of (Alphav)(Beta6) integrin" (American, British Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,796, issued on Sept. 16, was assigned to Morphic Therapeutic Inc. (Waltham, Mass.).

"Inhibitors of (Alphav)(Beta6) integrin" was invented by Mark Brewer (Wallingford, Great Britain), Matthew G. Bursavich (Needham, Mass.), Aleksey I. Gerasyuto (Flemington, N.J.), Kristopher N. Hahn (Medford, Mass.), Bryce A. Harrison (Framingham, Mass.), Kyle D. Konze (Katonah, N.Y.), Fu-Yang Lin (Sudbury, Mass.), Blaise S. Lippa (Newton, Mass.), Alexey A. Lugovskoy (Belmont, Mass.), Bruce N. Rogers (Belmont, Mass.), Mats A. Svensson (New York) and Dawn M. Troast (Bedford, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are small molecule inhibitors o...